Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial

BACKGROUND: Smoking rates are high in adults with anxiety disorders (ADs), yet little is known about the safety and efficacy of smoking‐cessation pharmacotherapies in this group. METHODS: Post hoc analyses in 712 smokers with AD (posttraumatic stress disorder [PTSD], n = 192; generalized anxiety dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayers, Catherine R., Heffner, Jaimee L., Russ, Cristina, Lawrence, David, McRae, Thomas, Evins, A. Eden, Anthenelli, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064930/
https://www.ncbi.nlm.nih.gov/pubmed/31850603
http://dx.doi.org/10.1002/da.22982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064930/
https://www.ncbi.nlm.nih.gov/pubmed/31850603
http://dx.doi.org/10.1002/da.22982

Ejemplares similares